Vaccine Therapy in Non-Small Cell Lung Cancer

Vaccine Therapy in Non-Small Cell Lung Cancer

Immunotherapy using immune checkpoint modulators has revolutionized the oncology field, emerging as a new standard of care for multiple indications, including non-small cell lung cancer (NSCLC). However, prognosis for patients with lung cancer is still poor. Although immunotherapy is highly effectiv...

Full description

Bibliographic Details
Main Authors: Miguel García-Pardo, Teresa Gorria, Ines Malenica, Stéphanie Corgnac, Cristina Teixidó, Laura Mezquita
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Vaccines
Subjects:
therapeutic cancer vaccine
neoantigen
non-small cell lung cancer
immune checkpoint inhibitor
tumor antigen
Online Access:https://www.mdpi.com/2076-393X/10/5/740

Similar Items

Similar Items